Leap Therapeutics (LPTX)
(Delayed Data from NSDQ)
$2.43 USD
+0.07 (2.97%)
Updated May 31, 2024 04:00 PM ET
After-Market: $2.40 -0.03 (-1.23%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, Leap Therapeutics (LPTX) reported earnings of -$0.51 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 10.53%. Look out for LPTX's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 53.85%.
Earnings History
Price & Consensus
Zacks News for LPTX
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
LPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services